Clinical Trials on Immune Checkpoints Inhibitors
Total 51125 results
-
Enzyre B.V.Instytut Hematologii i Transfuzjologii, Warschau, PolandCompletedHemophilia A | Hemophilia A With InhibitorPoland
-
Swedish Orphan BiovitrumCerner EnvizaCompletedHemophilia A With InhibitorFrance, Ireland, Italy, Norway, Germany, Kuwait, Saudi Arabia, Switzerland
-
Margaret RagniHealth Resources and Services Administration (HRSA)Terminated
-
Samsung Changwon HospitalUnknownPeptic Ulcer | Peptic Ulcer Hemorrhage | Peptic Ulcer, Acute With Hemorrhage | Proton Pump Inhibitor OverdoseKorea, Republic of
-
Nara Medical UniversityShireUnknownHemophilia A With InhibitorJapan
-
Skane University HospitalCompleted
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan
-
Nanfang Hospital of Southern Medical UniversityRecruitingEsophageal Squamous Cell Carcinoma | PD-1 InhibitorChina
-
Changi General HospitalCompletedArrhythmias, Cardiac | Seizures | Hypocalcemia | Hypokalemia | Hypomagnesemia | Proton Pump Inhibitor Adverse ReactionSingapore
-
Xiaorong DongUnknown
-
Skane University HospitalCompleted
-
Instituto de Investigación Marqués de ValdecillaWithdrawnCOVID 19 | Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
-
AryoGen Pharmed Co.CompletedHemophilia A or B With InhibitorIran, Islamic Republic of, Turkey
-
Grifols Italia S.p.AThrombinoscopeUnknownSevere Hemophilia A With InhibitorItaly
-
PfizerCompletedDiabetic Retinopathy | Diabetic Macular Edema | Anti- VGF InhibitorSpain, United Kingdom, Finland, Sweden
-
Ewha Womans University Mokdong HospitalEnrolling by invitationDiabetes Mellitus, Type 2 | Atrial Fibrillation | SGLT-2 InhibitorKorea, Republic of
-
HaemnetRoche ChugaiCompletedHemophilia A With InhibitorUnited Kingdom
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma (ESCC) | PD-1 InhibitorsChina
-
University Hospital, CaenCompleted
-
Grifols Therapeutics LLCTerminatedType 1 Diabetes MellitusUnited States
-
Affiliated Hospital of Guangdong Medical UniversityNot yet recruitingHemophilia B Without Inhibitor
-
Zhejiang UniversityNot yet recruitingHemophilia B Without Inhibitor
-
ApcinteX LtdCentessa Pharmaceuticals plcRecruitingHemophilia B | Hemophilia B With InhibitorUnited States, Spain, Australia, Taiwan, France, Armenia, Germany
-
Erasmus Medical CenterRecruitingNon Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase InhibitorNetherlands
-
Karen-Lise Garm SpindlerCompletedColorectal Cancer Metastatic | KRAS Gene Mutation | Circulating Tumor DNA | BRAF Gene Mutation | NRAS Gene Mutation | Epidermal Growth Factor Receptor InhibitorDenmark
-
Central Hospital, Nancy, FranceCompletedAdenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, SomaticFrance
-
Hangzhou Cancer HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)China
-
RenJi HospitalNot yet recruitingMyocardial Fibrosis | Obesity | Type 2 Diabetes | Magnetic Resonance Imaging | Sodium-glucose Co-transporter-2 Inhibitor
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingNasopharyngeal Carcinoma | Capecitabine | Radiotherapy | PD-1 InhibitorChina
-
BioMarin PharmaceuticalRecruitingHemophilia A With Inhibitor | Hemophilia A With Anti Factor VIIIUnited States, United Kingdom, Taiwan, Israel, Korea, Republic of, South Africa, Brazil, Italy, Germany
-
Southern Medical University, ChinaTerminatedDisease Progression | Proteinuria | Renal Insufficiency,Chronic | Dose-Response Relationship,Drug | ACE Inhibitor | Angiotensin II Type 1 Receptor BlockersChina
-
Yonsei UniversityTakedaRecruitingPlatinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP InhibitorKorea, Republic of
-
T. van der PollZonMw: The Netherlands Organisation for Health Research and Development; Prothya...Terminated
-
Gene SolutionsRecruitingNon Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase InhibitorsVietnam
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's Hospital and other collaboratorsNot yet recruitingNasopharyngeal Carcinoma | Neoadjuvant Therapy | PD-1 Inhibitor
-
National Taiwan University HospitalRecruitingPharmacokinetics | Therapeutic Drug Monitoring | Tyrosine Kinase InhibitorTaiwan
-
CENTOGENE GmbH RostockCompletedHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | C1 Esterase Inhibitor Deficiency | HAE | Angio Edema | C4 Deficiency | Hereditary Angioedema Type IIITurkey, Armenia, Georgia, India, Peru, Poland, Romania
-
Tang-Du HospitalRecruitingChemotherapy | Esophageal Squamous Cell Carcinoma | PD-1 Inhibitor | NeoadjuventChina
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
University Health Network, TorontoNot yet recruitingEnd Stage Kidney Disease | Kidney Dysfunction | Peritoneal Dialysis Complication | Sodium-glucose Co-transporter-2 Inhibitors | Residual Kidney FunctionCanada
-
Chulalongkorn UniversityRecruitingComparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia AJoint Bleed | Severe Hemophilia A Without InhibitorThailand
-
Tianjin Medical University Cancer Institute and...RecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung Cancer | Bevacizumab | Tyrosine Kinase InhibitorChina
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
University Hospital Inselspital, BerneRigshospitalet, Copenhagen, Denmark (Prof. Moller, Dr. Krag)CompletedCritical Illness | Acute Kidney Injury | Renal Replacement Therapy | End-stage Renal Disease | Proton Pump InhibitorDenmark, Switzerland
-
Imagine InstituteAssistance Publique - Hôpitaux de ParisCompletedPrimary Immuno-DeficienciesFrance
-
Khon Kaen UniversityThai Rheumatism AssociationCompletedGastroesophageal Reflux | Systemic Sclerosis | Proton Pubm Inhibitor
-
Chongqing University Cancer HospitalNot yet recruitingPARP Inhibitor for Esophageal Squamous Cell Carcinoma
-
CSL BehringCompletedCystic FibrosisBulgaria, Hungary, Poland, United Kingdom
-
Sun Yat-sen UniversityRecruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 InhibitorChina
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina